Human medicines European public assessment report (EPAR): Hyrimoz, adalimumab, Date of authorisation: 26/07/2018, Revision: 17, Status: Authorised

ICH E21 guideline on inclusion of pregnant and breastfeeding individuals in clinical trials – Scientific guideline

Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) multistakeholder workshop on Patient Registries for Alzheimer's disease, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 15 December 2025, 09:00 (CET) to 15 December 2025, 17:30 (CET)

Concept paper on new guidance on the clinical investigation of medicinal products for the treatment of idiopathic pulmonary fibrosis (IPF)

Concept paper on a paediatric update of the guideline on clinical investigation of medicinal products for the management of Crohn’s disease

Concept paper on a paediatric update on the guideline on the development of new medicinal products for the treatment of Ulcerative Colitis

EMEA-003156-PIP02-22

Records of data processing activity for internal publication of appointments, transfers and departures

Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Accord, sitagliptin,metformin hydrochloride, Date of authorisation: 22/07/2022, Revision: 3, Status: Lapsed